|
1
|
Xie Y, Tan Y and Tang S: Epidemiology of
377 patients with chemical burns in Guangdong province. Burns.
30:569–572. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang C and Xu J: Indications for
penetrating keratoplasty in East China, 1994–2003. Graefes Arch
Clin Exp Ophthalmol. 243:1005–1009. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hong J, Qiu T, Wei A, Sun X and Xu J:
Clinical characteristics and visual outcome of severe ocular
chemical injuries in Shanghai. Ophthalmology. 117:2268–2272. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saika S, Kobata S, Hashizume N, Okada Y
and Yamanaka O: Epithelial basement membrane in alkali-burned
corneas in rats. Immunohistochemical study. Cornea. 12:383–390.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ishizaki M, Zhu G, Haseba T, Shafer SS and
Kao WW: Expression of collagen I, smooth muscle alpha-actin, and
vimentin during the healing of alkali-burned and lacerated corneas.
Invest Ophthalmol Vis Sci. 34:3320–3328. 1993.PubMed/NCBI
|
|
6
|
Pandya NM, Dhalla NS and Santani DD:
Angiogenesis-a new target for future therapy. Vascul Pharmacol.
44:265–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Groot H, Schmit-Eilenberger V, Kirchhof
J and Augustin AJ: Angiostatic and angiogenic factors. Dev
Ophthalmol. 46:1–3. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ranganathan K and Sivasankar V:
MicroRNAs-Biology and clinical applications. J Oral Maxillofac
Pathol. 18:229–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ryan DG, Oliveira-Fernandes M and Lavker
RM: MicroRNAs of the mammalian eye display distinct and overlapping
tissue specificity. Mol Vis. 12:1175–1184. 2006.PubMed/NCBI
|
|
11
|
Karali M, Peluso I, Gennarino VA, Bilio M,
Verde R, Lago G, Dollé P and Banfi S: miRNeye: A microRNA
expression atlas of the mouse eye. BMC Genomics. 11:7152010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Würdinger T, Tannous BA, Saydam O, Skog J,
Grau S, Soutschek J, Weissleder R, Breakefield XO and Krichevsky
AM: miR-296 regulates growth factor receptor overexpression in
angiogenic endothelial cells. Cancer Cell. 14:382–393. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei JJ, Wu X, Peng Y, Shi G, Basturk O,
Yang X, Daniels G, Osman I, Ouyang J, Hernando E, et al: Regulation
of HMGA1 expression by microRNA-296 affects prostate cancer growth
and invasion. Clin Cancer Res. 17:1297–1305. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng J, Huang T, Huang Q, Chen H, Li Y, He
W, Wang GB, Zhang L, Xia J, Zhang N and Liu Y: Pro-angiogenic
microRNA-296 upregulates vascular endothelial growth factor and
downregulates Notch1 following cerebral ischemic injury. Mol Med
Rep. 12:8141–8147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bian F, Pelegrino FS, Henriksson JT,
Pflugfelder SC, Volpe EA, Li DQ and de Paiva CS: Differential
effects of dexamethasone and doxycycline on inflammation and MMP
production in alkali-burned corneas associated with dry eye. Ocul
Surf. 14:242–254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32(Database issue): D277–D280. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du J, Li M, Yuan Z, Guo M, Song J, Xie X
and Chen Y: A decision analysis model for KEGG pathway analysis.
BMC Bioinformatics. 17:4072016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khatri P, Sirota M and Butte AJ: Ten years
of pathway analysis: Current approaches and outstanding challenges.
PLoS Comput Biol. 8:e10023752012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilson SE, Mohan RR, Mohan RR, Ambrósio R
Jr, Hong J and Lee J: The corneal wound healing response:
Cytokine-mediated interaction of the epithelium, stroma, and
inflammatory cells. Prog Retin Eye Res. 20:625–637. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park JH, Joo CK and Chung SK: Comparative
study of tacrolimus and bevacizumab on corneal neovascularization
in rabbits. Cornea. 34:449–455. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakao S, Hata Y, Miura M, Noda K, Kimura
YN, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, et al:
Dexamethasone inhibits interleukin-1beta-induced corneal
neovascularization: Role of nuclear factor-kappaB-activated stromal
cells in inflammatory angiogenesis. Am J Pathol. 171:1058–1065.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakao S, Zandi S, Lara-Castillo N, Taher
M, Ishibashi T and Hafezi-Moghadam A: Larger therapeutic window for
steroid versus VEGF-A inhibitor in inflammatory angiogenesis:
Surprisingly similar impact on leukocyte infiltration. Invest
Ophthalmol Vis Sci. 53:3296–3302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan J, Zhai JJ, Chen JQ, Ye CT and Zhou
SY: Preparation of 0.05% FK506 suspension eyedrops and its
pharmacokinetics after topical ocular administration. J Ocul
Pharmacol Ther. 25:345–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
